Biotelemetry Inc (BEAT)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

1010 SECOND AVENUE SAN DIEGO, CA 92101

CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. It offers CardioNet System, which incorporates a patient-worn sensor attached to electrodes that capture two-lead electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its CardioNet System automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. The company also offers Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor; and event monitoring services to record and store approximately 540 seconds of ECG signal, as well as pacemaker monitoring services. It markets its arrhythmia monitoring solutions, including the CardioNet System, primarily to cardiologists and electrophysiologists.

Data as of 2020-06-27
Market Cap1.457 Billion Shares Outstanding34.145 Million Avg 30-day Volume292.072 Thousand
P/E Ratio65.1 Dividend Yield EPS0.69
Price/Sales3.252 Price cash flow ratio26.2 Price free cash flow ratio50.9
Book Value11.04 Price to Tangible Book-30.72 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.189089
BETA1.32662 52-week High/Low55.85 / 27.35 Stddev0.130151
View SEC Filings from BEAT instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 2 1 (0.07%)
13F Filers holding this stock: 203 46 (3.01%)
Aggregate 13F shares on 03/31/2020: 32.209 Million 16.12 Million
Aggregate 13F shares on 12/31/2019: 33.017 Million 14.714 Million
Percent change: -2.45% 9.56%
Funds creating new positions: 26 8
Funds Adding to an existing position: 68 20
Funds closing out their position: 36 10
Funds reducing their position: 78 14
Heat Map Ranking for 03/31/2020 149
Heat Map Ranking for 12/31/2019 91
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BEAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BEAT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MIDDLETON FRED A

  • Director
0 2020-06-11 0

HILL COLIN

  • Director
15,888 2020-05-13 1

GORMAN KIRK E

  • Director
181,146 2020-05-11 2

CONTI ANTHONY JAMES

  • Director
104,507 2020-05-11 1

FRICK JOSEPH A.

  • Director
61,124 2020-05-11 1

RIETIKER STEPHEN

  • Director
81,564 2020-05-11 1

OLSON TIFFANY

  • Director
6,642 2020-05-11 1

DIETCH LAURA N.

  • Director
5,893 2020-05-11 1

RUBIN ROBERT J.

  • Director
183,130 2020-05-03 1

RIMEL REBECCA W

  • Director
116,280 2020-05-03 1

STOICA ANDREI G SVP & CTO

  • Officer
30,000 2020-04-06 2

THURMAN RANDY H

  • Director
0 2020-03-19 0

GETZ HEATHER C EVP, CFO & CAO

  • Officer
49,183 2020-02-18 2

CAPPER JOSEPH H PRESIDENT & CEO

  • Officer
  • Director
168,372 2020-02-18 2

WISNIEWSKI DANIEL SVP, TECHNICAL OPERATIONS

  • Officer
24,817 2020-02-18 2

BROADWAY FRED PRESIDENT BIOTEL HEART

  • Officer
28,350 2020-02-18 2

WADHWA MANISH SVP & CMO

  • Officer
2,120 2020-02-18 2

FEROLA PETER SVP & GENERAL COUNSEL

  • Officer
8,507 2019-12-31 2

GALVAN MARTIN P FORMER VP OF FINANCE & CFO

  • Officer
102,409 2019-08-30 0

MYERS WOODROW A JR

  • Director
0 2018-12-20 0

MARGOLIES MATTHEW PRESIDENT

  • Officer
No longer subject to file 2017-12-28 0

HRENKO GEORGE SVP - HUMAN RESOURCES

  • Officer
20,518 2017-02-27 0

PRYSTOWSKY ERIC N

  • Director
52,593 2016-05-24 0

REIN HARRY T

  • Director
No longer subject to file 2016-03-14 0

GELDART MICHAEL SENIOR VICE PRESIDENT

  • Officer
65,396 2015-06-17 0

AHRENS RONALD A

  • Director
196,670 2015-04-30 0

MCNAMARA ANNA SENIOR VICE PRES/CLINICAL OP.

  • Officer
90,903 2013-02-19 0

GROPPER CHARLES SENIOR VICE PRESIDENT

  • Officer
51,422 2012-02-21 0

SCHULER ANTHONY SENIOR VICE PRESIDENT

  • Officer
25,121 2012-02-21 0

KASRAWI JAREER SENIOR VICE PRESIDENT

  • Officer
26,075 2012-02-21 0

LEONE PHILIP SENIOR VICE PRESIDENT

  • Officer
43,655 2011-03-04 0

IMPERATO JOHN F SENIOR VICE PRESIDENT

  • Officer
39,179 2010-05-10 0

SWEENEY JAMES M

  • Director
635,966 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
944,366 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
631,829 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
716,018 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

  • 10% Owner
357,461 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
1,484,576 2008-03-25 0

GUIDANT INVESTMENT CORP

  • 10% Owner
No longer subject to file 2008-03-25 0

COHEN ARIE PRESIDENT AND CEO

  • Officer
  • Director
0 2008-03-18 0

GEROLAMO EMMANUEL SENIOR VP SALES & MARKETING

  • Officer
0 2008-03-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HILL COLIN - Director

2020-05-11 A 2,863 a 21,654 21,654.00 direct

FRICK JOSEPH A. - Director

2020-05-11 A 3,662 a 61,124 61,124.00 direct

OLSON TIFFANY - Director

2020-05-11 A 3,635 a 6,642 6,642.00 direct

RUBIN ROBERT J. - Director

2020-05-11 A 4,074 a 161,093 183,130.00 direct

GORMAN KIRK E - Director

2020-05-11 A 4,241 a 167,955 181,146.00 direct

CONTI ANTHONY JAMES - Director

2020-05-11 A 2,863 a 104,507 104,507.00 direct

RIMEL REBECCA W - Director

2020-05-11 A 2,863 a 116,280 116,280.00 direct

RIETIKER STEPHEN - Director

2020-05-11 A 2,863 a 81,564 81,564.00 direct

DIETCH LAURA N. - Director

2020-05-11 A 3,469 a 5,893 5,893.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments